- Home
- APGE vs LGND Comparison
APGE vs LGND Comparison
Compare APGE & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- LGND
- Stock Information
- Founded
- APGE 2022
- LGND 1987
- Country
- APGE United States
- LGND United States
- Employees
- APGE N/A
- LGND N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- APGE Health Care
- LGND Health Care
- Exchange
- APGE Nasdaq
- LGND Nasdaq
- Market Cap
- APGE 2.1B
- LGND 2.1B
- IPO Year
- APGE 2023
- LGND 1992
- Fundamental
- Price
- APGE $37.29
- LGND $104.48
- Analyst Decision
- APGE Strong Buy
- LGND Strong Buy
- Analyst Count
- APGE 4
- LGND 8
- Target Price
- APGE $91.33
- LGND $144.71
- AVG Volume (30 Days)
- APGE 545.3K
- LGND 102.0K
- Earning Date
- APGE 05-20-2025
- LGND 05-08-2025
- Dividend Yield
- APGE N/A
- LGND N/A
- EPS Growth
- APGE N/A
- LGND N/A
- EPS
- APGE N/A
- LGND N/A
- Revenue
- APGE N/A
- LGND $181,488,000.00
- Revenue This Year
- APGE N/A
- LGND $16.47
- Revenue Next Year
- APGE $743.14
- LGND $19.44
- P/E Ratio
- APGE N/A
- LGND N/A
- Revenue Growth
- APGE N/A
- LGND 53.40
- 52 Week Low
- APGE $26.20
- LGND $72.61
- 52 Week High
- APGE $63.50
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- APGE 52.37
- LGND 46.11
- Support Level
- APGE $34.38
- LGND $99.24
- Resistance Level
- APGE $41.05
- LGND $107.37
- Average True Range (ATR)
- APGE 2.23
- LGND 4.05
- MACD
- APGE 0.10
- LGND -0.33
- Stochastic Oscillator
- APGE 51.48
- LGND 39.37
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.